Physician profile
Theodore Chow
NPI 1104803048
$17,752.27
in general payments reported to CMS, 2019-2025
35 companies · $3,056 in 2025
The $3,056 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,749 · 2020: $589 · 2021: $1,513 · 2022: $4,061 · 2023: $2,193 · 2024: $2,592 · 2025: $3,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,241 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,240.50 |
| Travel and Lodging | $600.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,373.74 | 2019-2025 | Jot Dx, Gallant, Assurity |
| Biotronik INC. | $3,442.40 | 2019-2025 | Biomonitor, Amvia Edge, Renamic Neo |
| Medical Device Business Services, INC. | $1,988.85 | 2022 | |
| Amgen INC. | $1,078.28 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,046.26 | 2021-2025 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $841.07 | 2022-2025 | Camzyos, Eliquis |
| Biosense Webster, INC. | $723.75 | 2019-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $605.42 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $416.06 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $369.77 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.49 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $322.03 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.61 | 2023-2025 | Lifevest |
| Medtronic Vascular, INC. | $214.33 | 2019-2020 | |
| Pfizer INC. | $209.98 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $204.88 | 2022-2024 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $154.05 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $153.37 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $140.91 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $115.57 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $106.62 | 2021-2024 | Micra |
| Kiniksa Pharmaceuticals, LTD. | $102.31 | 2022-2023 | Arcalyst |
| Boston Scientific Corporation | $99.21 | 2024-2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $82.99 | 2020-2024 | |
| Bridgebio Pharma, INC. | $66.31 | 2025 | Attruby |
| Lundbeck LLC | $64.32 | 2019-2020 | |
| Heartflow, INC. | $45.47 | 2025 | |
| Edwards Lifesciences Corporation | $36.70 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Akcea Therapeutics, INC. | $33.30 | 2020 | |
| Alnylam Pharmaceuticals INC. | $32.41 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $30.60 | 2025 | |
| Philips North America LLC | $25.67 | 2020 | |
| Baxter Healthcare | $24.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $21.65 | 2019 | |
| Bardy Diagnostics, INC. | $17.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.